GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Shyndec Pharmaceutical Co Ltd (SHSE:600420) » Definitions » Intrinsic Value: Projected FCF

Shanghai Shyndec Pharmaceutical Co (SHSE:600420) Intrinsic Value: Projected FCF : ¥18.78 (As of Jun. 05, 2025)


View and export this data going back to 2004. Start your Free Trial

What is Shanghai Shyndec Pharmaceutical Co Intrinsic Value: Projected FCF?

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.

As of today (2025-06-05), Shanghai Shyndec Pharmaceutical Co's Intrinsic Value: Projected FCF is ¥18.78. The stock price of Shanghai Shyndec Pharmaceutical Co is ¥10.75. Therefore, Shanghai Shyndec Pharmaceutical Co's Price-to-Intrinsic-Value-Projected-FCF of today is 0.6.

The historical rank and industry rank for Shanghai Shyndec Pharmaceutical Co's Intrinsic Value: Projected FCF or its related term are showing as below:

SHSE:600420' s Price-to-Projected-FCF Range Over the Past 10 Years
Min: 0.45   Med: 0.61   Max: 5.43
Current: 0.57

During the past 13 years, the highest Price-to-Intrinsic-Value-Projected-FCF of Shanghai Shyndec Pharmaceutical Co was 5.43. The lowest was 0.45. And the median was 0.61.

SHSE:600420's Price-to-Projected-FCF is ranked better than
89.98% of 619 companies
in the Drug Manufacturers industry
Industry Median: 1.61 vs SHSE:600420: 0.57

Shanghai Shyndec Pharmaceutical Co Intrinsic Value: Projected FCF Historical Data

The historical data trend for Shanghai Shyndec Pharmaceutical Co's Intrinsic Value: Projected FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Shyndec Pharmaceutical Co Intrinsic Value: Projected FCF Chart

Shanghai Shyndec Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Intrinsic Value: Projected FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.06 16.90 19.50 18.81 19.09

Shanghai Shyndec Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Intrinsic Value: Projected FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.86 18.98 19.25 19.09 18.78

Competitive Comparison of Shanghai Shyndec Pharmaceutical Co's Intrinsic Value: Projected FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Shanghai Shyndec Pharmaceutical Co's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Shyndec Pharmaceutical Co's Price-to-Projected-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shanghai Shyndec Pharmaceutical Co's Price-to-Projected-FCF distribution charts can be found below:

* The bar in red indicates where Shanghai Shyndec Pharmaceutical Co's Price-to-Projected-FCF falls into.


;
;

Shanghai Shyndec Pharmaceutical Co Intrinsic Value: Projected FCF Calculation

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.

The details of how we calculate the intrinsic value of stocks are described in detail here.

This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)

In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)


Add all the Free Cash Flow together and divide 6 will get Shanghai Shyndec Pharmaceutical Co's Free Cash Flow(6 year avg) = ¥1,505.00.

Shanghai Shyndec Pharmaceutical Co's Intrinsic Value: Projected FCF for today is calculated as

Intrinsic Value: Projected FCF=(Growth Multiple*Free Cash Flow (6 year avg)+Total Stockholders Equity (Mar25)*0.8)/Shares Outstanding (Diluted Average)
=(9.5203515959648*1505+13565.338*0.8)/1341.053
=18.78

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai Shyndec Pharmaceutical Co  (SHSE:600420) Intrinsic Value: Projected FCF Explanation

The growth multiple is capped between 8.35 and 17.74.

Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.

Shanghai Shyndec Pharmaceutical Co's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as

Price-to-Intrinsic-Value-Projected-FCF=Share Price/Intrinsic Value: Projected FCF
=10.75/18.77658791407
=0.57

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai Shyndec Pharmaceutical Co Intrinsic Value: Projected FCF Related Terms

Thank you for viewing the detailed overview of Shanghai Shyndec Pharmaceutical Co's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Shyndec Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No.1320 Beijinxi Road, Shanghai, CHN, 200040
Shanghai Shyndec Pharmaceutical Co Ltd engages in the research, development, production, and sale of pharmaceutical preparations, biological pharmaceuticals, chemical raw materials, and Chinese medicine formulations in China and internationally. It provides biological and chemical raw material medicines, microbial fermentation products and tablets, capsules, granules, injections, suspensions, and suppositories, as well as ointments, including product formulations.
Executives
Li Hao senior management
Ni Feng Director
Li Xian Lin senior management
Hao Chao Feng senior management
Lian Wan Yong Director
Han Yan Lin Director
Yang Wen Ming Supervisors
Feng Ming Director

Shanghai Shyndec Pharmaceutical Co Headlines

No Headlines